ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Bayer A.G.
15.66
-0.0100
-0.06%
盤後:
15.66
0.0000
0.00%
16:00 EST
成交量:
54.44萬
成交額:
852.31萬
市值:
615.39億
市盈率:
-37.45
高:
15.72
開:
15.63
低:
15.60
收:
15.67
52周最高:
15.98
52周最低:
7.65
股本:
39.30億
流通股本:
39.29億
量比:
0.34
換手率:
0.01%
股息:
0.03
股息率:
0.20%
每股收益(TTM):
-0.4181
每股收益(LYR):
-0.6723
淨資產收益率:
-4.56%
總資產收益率:
4.34%
市淨率:
1.91
市盈率(LYR):
-23.29
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
輝瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)尋求駁回拜耳旗下孟山都mRNA專利訴訟遭法官拒絕
智通财经
·
09/29
拜耳(BAYRY)腎病藥物可仁達®獲FDA批新適應症 填補1型糖尿病併發症30年空白
金吾财讯
·
09/17
阿波羅(APO)聯合KKR(KKR)完成對拜耳(BAYRY)30億歐元資本解決方案交易
金吾财讯
·
09/16
拜耳(BAYRY)二季度Non-GAAP每股盈利達0.95歐元勝預期
金吾财讯
·
08/04
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BAYRY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BAYRY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","market":"US","secType":"STK","nameCN":"Bayer A.G.","latestPrice":15.66,"timestamp":1794603600000,"preClose":15.67,"halted":0,"volume":544421,"hourTrading":{"tag":"盘后","latestPrice":15.66,"preClose":15.66,"latestTime":"16:00 EST","volume":1298,"amount":20315.940000000002,"timestamp":1794603640964,"change":0,"changeRate":0,"amplitude":0.000639},"delay":15,"changeRate":-0.000638162093171652,"floatShares":3929259738,"shares":3929696328,"eps":-0.41815,"marketStatus":"已收盤","change":-0.01,"latestTime":"11-13 16:00:40 EST 延時","open":15.63,"high":15.715,"low":15.6,"amount":8523143.572799996,"amplitude":0.007339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.41815,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"OTCQX","adjPreClose":15.67,"volumeRatio":0.34397},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BAYRY\",,,,,undefined,":{"symbol":"BAYRY","floatShares":3929259738,"roa":"4.34%","roe":"-4.56%","lyrEps":-0.672343,"volumeRatio":0.34397,"shares":3929696328,"dividePrice":0.031526,"high":15.715,"amplitude":0.007339,"preClose":15.67,"low":15.6,"week52Low":7.65,"pbRate":"1.91","psRate":"1.22","week52High":15.98,"institutionHeld":0.0017,"latestPrice":15.66,"eps":-0.41815,"divideRate":0.002013,"volume":544421,"delay":15,"ttmEps":-0.41815,"open":15.63,"prevYearClose":10.82,"prevWeekClose":15.33,"prevMonthClose":13.99,"prevQuarterClose":13.5,"fiveDayClose":15.33,"twentyDayClose":12.47,"sixtyDayClose":14.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BAYRY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"","actualEps":null},{"date":"2026-04-28","symbol":"BAYRY","amount":0.031526,"announcedDate":"2026-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-11","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-05-11"},{"market":"US","date":"2025-05-13","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"","actualEps":null},{"date":"2025-04-29","symbol":"BAYRY","amount":0.030365,"announcedDate":"2025-04-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-29","defaultRemindTime":1745933400000,"name":"Bayer A.G.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-12","payableDate":"2025-04-29","currency":"USD","dateTimestamp":1745899200000,"payDate":"2025-05-12"},{"market":"US","date":"2024-11-12","symbol":"BAYRY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BAYRY\",market:\"US\",,,undefined,":[{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-05-13","value":0.550569,"currency":"USD"},{"executeDate":"2020-04-29","recordDate":"2020-04-30","paymentDate":"2020-05-14","value":0.535933,"currency":"USD"},{"executeDate":"2021-04-28","recordDate":"2021-04-29","paymentDate":"2021-05-10","value":0.407111,"currency":"USD"},{"executeDate":"2022-05-02","recordDate":"2022-05-03","paymentDate":"2022-05-16","value":0.549114,"currency":"USD"},{"executeDate":"2023-05-02","recordDate":"2023-05-03","paymentDate":"2023-05-15","value":0.6318,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BAYRY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1783918800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BAYRY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671326261","title":"輝瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)尋求駁回拜耳旗下孟山都mRNA專利訴訟遭法官拒絕","url":"https://stock-news.laohu8.com/highlight/detail?id=2671326261","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671326261?lang=zh_tw&edition=fundamental","pubTime":"2026-09-29 10:28","pubTimestamp":1790648936,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国特拉华州一名联邦法官周一驳回了辉瑞、BioNTech和Moderna提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼,该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。要知道,辉瑞/BioNTech的疫苗Comirnaty已创下超930亿美元的销售额,这也让拜耳的维权诉求更受关注。Moderna曾辩称,该专利涉及的是不可授予专利的“自然法则”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0792757196.USD","IE00BSNM7G36.USD","LU1551013425.SGD","LU1585245621.USD","LU0545562505.USD","BK4559","LU2750360641.GBP","IE00B7SZLL34.SGD","LU1894683348.USD","LU2471134523.USD","BNTX","LU0225284248.USD","LU1430594728.SGD","LU2133065610.SGD","LU0234570918.USD","LU0057025933.USD","LU1983299246.USD","LU1043141123.HKD","LU1935042991.SGD","LU0289961442.SGD","LU1291159041.SGD","BK4568","LU0289739699.SGD","LU0203345920.USD","SGXZ57979304.SGD","LU1244550577.SGD","LU1066053197.SGD","LU2129689431.USD","IE00BKVL7J92.USD","IHE","LU1883839398.USD","LU2112291526.USD","IE00B3T34201.USD","LU2471134879.HKD","XLV","LU0053666078.USD","LU0072461881.USD","LU0820562030.AUD","LU0949170772.SGD","LU2756315664.SGD","SG9999011175.SGD","LU0345769128.USD","IE00BN8TJ469.HKD","LU2417539215.USD","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU2023250330.USD","LU0943347566.SGD","LU1032466523.USD","LU0868494617.USD","BK4548","LU1003077747.HKD","LU0114720955.EUR","BK4139","LU0787776722.HKD","LU2896262040.SGD","BK4532","LU0683600562.USD","LU0795875086.SGD","BK4585","IE00B1BXHZ80.USD","LU1551013342.USD","LU1023059063.AUD","LU1121112475.USD","LU1228905037.USD","IE00B42XCP33.USD","LU0889566641.SGD","PJP","LU0994945656.USD","BK4599","LU0058720904.USD","PFE","IE00BBT3K403.USD","BK4588","IE0002270589.USD","LU1162221912.USD","LU2468319806.SGD","LU1066051225.USD","LU0234572021.USD","LU2347655156.SGD","LU0321505439.SGD","BK4504","LU2505996509.AUD","LU1228905540.USD","LU1061106388.HKD","LU2236285917.USD","LU0210528500.USD","IE0002141913.USD","LU0098860793.USD","LU0553294199.USD","BK4534","IE000F7OJYX1.SGD","LU1778281490.HKD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0345770308.USD","MRNY","LU1221951129.SGD","LGHT","BAYRY","IE00B19Z3581.USD","OZEM","FTXH","LU0345769631.USD","LU1496350502.SGD","LU0882574055.USD","LU1074936037.SGD","IE00BLSP4239.USD","GDOC","BK4501","LU0661504455.SGD","LU0289739343.SGD","LU1032955483.USD","IXJ","LU1674673691.USD","SG9999003800.SGD","LU0985481810.HKD","LU2129689514.USD","SG9999001440.SGD","LU0689472784.USD","LU1221951046.USD","IYH","LU0321505868.SGD","LU2602419157.SGD","LU0345770993.USD","LU2089984988.USD","MEDX","LU2471134952.CNY","LU0210536198.USD","LU2487616109.SGD","IE000WAW04H5.SGD","LU0426412945.USD","LU0738911758.USD","LU0225771236.USD","IE0009355771.USD","LU1261432733.SGD","JDOC","LU2592432038.USD","SG9999002224.SGD","LU1989771016.USD","IE00BZ1G4Q59.USD","LU0466842654.USD","LU1914381329.SGD","IE00B3PB1722.GBP","LU0306807586.USD","LU1196500208.SGD","LU1043141396.HKD","LU2750360997.AUD","LU0472753341.HKD","BK4007","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU2456880835.USD","VHT","SG9999013999.USD","MRNX","IE000SO60NU8.SGD","LU1057294990.SGD","LU1280957306.USD","SG9999002232.USD","LU1244550221.USD","LU1929549753.HKD","FHLC","JNJ","BK4592","IE00BLSP4452.SGD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU0162691827.USD","LU2403377893.USD","LU0456855351.SGD","LU0070217475.USD","LU1674673428.USD","LU0820561818.USD","LU1066051498.USD","SG9999001176.USD","IE000MB6IJN5.SGD","LU1059921491.USD","IE0000B7K699.USD","LU1267930813.SGD","LU1732800096.USD","LU2756315318.SGD","BK4533","LU0511384066.AUD","IE00BVYPNW00.USD","LU0170899867.USD","BMED","LU0545039389.USD","LU1145028129.USD","IE00BVYPNV92.GBP","LU2430703095.HKD","LU2596442595.SGD","BK4550","IE00BFTCPJ56.SGD","IE0034235303.USD","LU0203347892.USD","IE00BFXG1179.USD","LU0320765646.SGD","LU1718418525.SGD","LU1894683264.USD","IE0001KFT4U8.USD","BK4535","LU2213496289.HKD","IE00BGHQF631.EUR","LU0640476718.USD","LU2471134796.USD","SGXZ80539844.SGD","WDNA","LU2430703178.SGD","LU0306806265.USD","TRUH","LU2430703251.USD","LU1629891620.HKD","LU0795875169.SGD","RXL","LU2505996681.GBP","MRNA","LU0124676726.USD","LU0912757837.SGD","LU0122379950.USD","LU1244550494.USD","SG9999001176.SGD","LU0432979614.USD","IE00B4R5TH58.HKD","LU0689626769.HKD","BK4551","LU1506573853.SGD","IE00B2B36J28.USD","LU0964807845.USD","LU0985320562.USD","LU0820561909.HKD","LU0426417589.USD","LU1732799900.SGD","BK4581","LU0069063385.USD","GNOM","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963269","title":"拜耳(BAYRY)腎病藥物可仁達®獲FDA批新適應症 填補1型糖尿病併發症30年空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963269","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 17:35","pubTimestamp":1789637756,"startTime":"0","endTime":"0","summary":"本次获批使可仁达成为30多年来首个获批用于治疗1型糖尿病相关慢性肾脏病的创新疗法。这是FDA批准该药的第三个适应症,进一步奠定了其在心肾并发症治疗领域的市场地位。拜耳方面表示,可仁达作为目前唯一获批可同时覆盖1型和2型糖尿病相关慢性肾脏病的口服每日一次MRA药物,将有效填补长期以来的临床空白,并持续巩固公司在心血管及肾脏疾病领域的全球领跑优势。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306150","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","BAYRY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667019786","title":"阿波羅(APO)聯合KKR(KKR)完成對拜耳(BAYRY)30億歐元資本解決方案交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667019786","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667019786?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:27","pubTimestamp":1789550861,"startTime":"0","endTime":"0","summary":"金吾财讯 | 阿波罗全球管理 宣布,已与知名私募股权机构KKR共同完成了对德国生命科学巨头拜耳价值30亿欧元的资本解决方案交易。根据交易安排,阿波罗联合作为重要少数股权投资方加入的KKR,共同向一家新成立的实体注入股权资本。该实体持有拜耳的长效可逆避孕药业务。阿波罗合伙人Jamshid Ehsani表示,此项定制化的数十亿欧元资本方案符合其“投资级资本解决方案”业务的发展方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B775SV38.USD","LU1935042991.SGD","LU0130102774.USD","LU1935043023.USD","PRVT","BK4585","BK4184","IE00B64PRP62.GBP","LU1323610961.USD","LU1935042215.USD","AAUM","BK4007","LU1668664300.SGD","BAYRY","LU0683600562.USD","KKR","LU1791807156.HKD","LU0106831901.USD","NBIE","FXE","LU0787776722.HKD","IE00B3S45H60.SGD","LU0648001328.SGD","LU1935043536.SGD","APO","EURmain","LU0314104364.USD","EUO","IE0002270589.USD","BK4135","LU0006061336.USD","IE00B19Z3B42.SGD","PSP","LBO","MEURmain","GPZ","BK4588","LU0980610538.SGD","LU1201861249.SGD","IE00B19Z3581.USD","LU1935042488.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656007535","title":"拜耳(BAYRY)二季度Non-GAAP每股盈利達0.95歐元勝預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656007535","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656007535?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:16","pubTimestamp":1785831386,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德国医药与农化巨头拜耳 发布2026财年第二季度财报。数据显示,二季度公司Non-GAAP每股收益达0.95欧元,超出市场预期0.20欧元;扣除特殊项目前的息税折旧及摊销前利润同比增长1.9%至21.44亿欧元。基于2026年6月30日的最新汇率预估,拜耳将全年集团销售额指引微调至447亿至467亿欧元,核心每股收益指引上调至4.20至4.70欧元。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZTU0NWNjNjJlNDMyOWFlYTQ0MTc4YmQzNzNjNjM2NzgyMTUxODUw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZTU0NWNjNjJlNDMyOWFlYTQ0MTc4YmQzNzNjNjM2NzgyMTUxODUw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303360","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEURmain","FXE","EURmain","BK4007","BAYRY","EUO","NBIE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BAYRY\",params:#limit:6,delay:false,,,undefined,":[]}}